A tragic incident has come to light in Australia, where a woman named Trish Webster, aged 56, lost her life after taking the prescription drug Ozempic as part of her weight loss journey.
Trish had been prescribed this drug in a bid to fit into a dress for her daughter's wedding. Regrettably, her use of Ozempic led to severe gastrointestinal problems, which ultimately proved fatal.
Her husband, Roy Webster, attributes these issues to the drug.
Originally approved by the US Food and Drug Administration for individuals with Type 2 diabetes, Ozempic has gained popularity as a weight loss aid. It achieves this by prolonging the feeling of fullness through slowing down the digestive process.
However, complications can arise, such as intestinal blockage, known as 'ileus.'
Roy Webster, speaking on a recent episode of 60 Minutes Australia, cautioned against using Ozempic for weight loss. He revealed that a doctor 'who thought it was a good idea' had prescribed the drug, however, he clarified that she didn't have diabetes.
Although Trish did shed 16 kilograms in five months with the help of Ozempic and another weight loss medication called Saxenda, it came at a considerable cost to her health, making her profoundly unwell.
"She went back to the doctor a couple times saying she is sick. She had diarrhea and nausea," Roy Webster shared.
He shared that his wife made the decision to persist with the medications despite experiencing discomfort, all because she was seeing positive results and hoped the nausea and diarrhea would eventually subside.
However, tragedy struck when he discovered his wife unresponsive on January 16, several months prior to their daughter's scheduled wedding.
Reflecting on this heart-wrenching incident during his appearance on 60 Minutes Australia, he recounted the harrowing experience:
"She had a little bit of brown stuff coming out of her mouth, and I realized she wasn't breathing and started doing CPR."
"It was just pouring out, and I turned her onto the side because she couldn't breathe."
Roy said: "If I knew that could happen, she wouldn't have been taking it. I never thought you could die from it.
"She shouldn't be gone, you know. It's just not worth it, it's not worth it at all."
Trish passed away that fateful evening.
In an interview with 60 Minutes Australia, Novo Nordisk, the company behind Ozempic, discussed the cases of ileus associated with their drug.
They mentioned that reports of ileus had only surfaced after the drug had already entered the market, indicating that they became aware of this issue following its public release.
By late September, the FDA had received 18 reports of ileus occurring in individuals who had taken Ozempic.